Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Smoking Cessation and Continued Risk in Cancer Patients (PDQ®)
Patient Version
Health Professional Version
En español
Last Modified:
08/14/2008
Nicotine Lozenges
Brand
Dose
Side Effects
Comments
OTC = over the counter.
OTC
Commit
40–80 mg/day
Local irritation (warmth and tingling)
Use for 12 weeks; max 20 pieces/day. Weeks 1–6: 1–2 lozenges every 1–2 hours; weeks 7–9: 1 lozenge every 2–4 hours; weeks 10–12: 1 lozenge every 4–8 hours.
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute